These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30207194)

  • 1. Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl
    Karimi J; Mohammadalipour A; Sheikh N; Khodadadi I; Hashemnia M; Goudarzi F; Khanjarsim V; Solgi G; Hajilooi M; Bahabadi M; Kheiripour N; Hedayatyanfard K
    Drug Chem Toxicol; 2020 Sep; 43(5):468-478. PubMed ID: 30207194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
    Wei YH; Jun L; Qiang CJ
    Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the effectiveness of tyrosine kinase inhibitor (TKI) in combination with a statin in reducing liver fibrosis.
    Mohammadalipour A; Hashemnia M; Goudarzi F; Ravan AP
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1183-1193. PubMed ID: 31396972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    El-Demerdash E; Salam OM; El-Batran SA; Abdallah HM; Shaffie NM
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):159-67. PubMed ID: 17900296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats.
    Ekor M; Odewabi AO; Kale OE; Oritogun KS; Adesanoye OA; Bamidele TO
    Hum Exp Toxicol; 2011 Nov; 30(11):1840-8. PubMed ID: 21357630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
    El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
    Moreno M; Gonzalo T; Kok RJ; Sancho-Bru P; van Beuge M; Swart J; Prakash J; Temming K; Fondevila C; Beljaars L; Lacombe M; van der Hoeven P; Arroyo V; Poelstra K; Brenner DA; Ginès P; Bataller R
    Hepatology; 2010 Mar; 51(3):942-52. PubMed ID: 20044807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
    Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the angiotensin II receptor, type 1 receptor antagonists, losartan and telmisartan, on thioacetamide-induced liver fibrosis in rats.
    Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Madro A; Brzozowski T
    J Physiol Pharmacol; 2016 Aug; 67(4):575-586. PubMed ID: 27779478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
    Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H
    Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
    Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
    Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.
    Shaker ME; Zalata KR; Mehal WZ; Shiha GE; Ibrahim TM
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):165-75. PubMed ID: 21316382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
    Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
    J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl
    Mohammadalipour A; Karimi J; Khodadadi I; Solgi G; Hashemnia M; Sheikh N; Bahabadi M
    Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):19-27. PubMed ID: 27908221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective Effects of Grape Seed Procyanidin B2 in Rats With Carbon Tetrachloride-induced Hepatic Fibrosis.
    Wang Z; Zhang Z; Du N; Wang K; Li L
    Altern Ther Health Med; 2015; 21 Suppl 2():12-21. PubMed ID: 26308756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
    Guo F; Sun YB; Su L; Li S; Liu ZF; Li J; Hu XT; Li J
    Hum Exp Toxicol; 2015 May; 34(5):497-505. PubMed ID: 25233898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways.
    Hernández-Aquino E; Zarco N; Casas-Grajales S; Ramos-Tovar E; Flores-Beltrán RE; Arauz J; Shibayama M; Favari L; Tsutsumi V; Segovia J; Muriel P
    World J Gastroenterol; 2017 Jun; 23(24):4354-4368. PubMed ID: 28706418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
    Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
    J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: Oxidative stress/TGF-β
    Atallah MAA; Elaidy SM; Tawfik MK
    Pharmacol Rep; 2018 Jun; 70(3):509-518. PubMed ID: 29660654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filtrate of fermented mycelia from Antrodia camphorata reduces liver fibrosis induced by carbon tetrachloride in rats.
    Lin WC; Kuo SC; Lin WL; Fang HL; Wang BC
    World J Gastroenterol; 2006 Apr; 12(15):2369-74. PubMed ID: 16688827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.